Avidity Biosciences
RNAM
#1795
Rank
โ‚ฌ9.69 B
Marketcap
62,78ย โ‚ฌ
Share price
0.00%
Change (1 day)
129.59%
Change (1 year)

Revenue for Avidity Biosciences (RNAM)

Revenue in 2025 (TTM): โ‚ฌ16.07 Million

According to Avidity Biosciences's latest financial reports the company's current revenue (TTM ) is โ‚ฌ16.16 Million. an increase over the revenue in the year 2024 that were of โ‚ฌ10.47 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avidity Biosciences from 2019 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ15.96 M52.46%
2024 โ‚ฌ10.47 M21.09%
2023 โ‚ฌ8.64 M0.57%
2022 โ‚ฌ8.59 M4.42%
2021 โ‚ฌ8.23 M49.24%
2020 โ‚ฌ5.51 M166.55%
2019 โ‚ฌ2.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ53.94 B 333,565.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ37.73 B 233,292.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚ฌ2.08 B 12,769.71%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚ฌ1.49 B 9,127.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚ฌ6.15 M-61.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ99.71 M 516.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚ฌ97.21 M 501.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.50 B 3,040.44%๐Ÿ‡บ๐Ÿ‡ธ USA